Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suraj Peri

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Plos One|April 25, 2013
Anti-CD70 immunocytokines for exploitation of interferon-γ-induced RIP1-dependent necrosis in renal cell carcinomaPeirong Chen, Shoko Nogusa, Roshan J Thapa, et al.
DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes|November 24, 2005
A bioinformatics analysis of protein tyrosine phosphatases in humansT K B Gandhi, Sreenath Chandran, Suraj Peri, et al.
Molecular Cancer Therapeutics|May 10, 2013
NF-κB inhibition by bortezomib permits IFN-γ-activated RIP1 kinase-dependent necrosis in renal cell carcinomaRoshan J Thapa, Peirong Chen, Mitchell Cheung, et al.
Plos One|October 4, 2019
RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistanceShuyun Rao, Suraj Peri, Jens Hoffmann, et al.
Frontiers in Oncology|August 5, 2025
Bladder cancer microbiome and its association with chemoresponseRashida Ginwala, Laura Bukavina, Mohit Sindhani, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Unique vulnerability of <i>RAC1</i>-mutant melanoma to combined inhibition of CDK9 and immune checkpointsAlexa C Cannon, Konstantin Budagyan, Cristina Uribe-Alvarez, et al.
Plos Pathogens|December 19, 2014
Cellular oxidative stress response controls the antiviral and apoptotic programs in dengue virus-infected dendritic cellsDavid Olagnier, Suraj Peri, Courtney Steel, et al.
Oncogene|January 19, 2024
Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpointsAlexa C Cannon, Konstantin Budagyan, Cristina Uribe-Alvarez, et al.
Molecular & Cellular Proteomics : MCP|September 30, 2020
Kinome Profiling of Primary Endometrial Tumors Using Multiplexed Inhibitor Beads and Mass Spectrometry Identifies SRPK1 as Candidate Therapeutic TargetAlison M Kurimchak, Vikas Kumar, Carlos Herrera-Montávez, et al.
Molecular Biology and Evolution|October 9, 2018
Functional Conservation of a Developmental Switch in Mammals since the Jurassic AgeJayati Mookerjee-Basu, Xiang Hua, Lu Ge, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Plos One|April 25, 2013
Anti-CD70 immunocytokines for exploitation of interferon-γ-induced RIP1-dependent necrosis in renal cell carcinomaPeirong Chen, Shoko Nogusa, Roshan J Thapa, et al.
DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes|November 24, 2005
A bioinformatics analysis of protein tyrosine phosphatases in humansT K B Gandhi, Sreenath Chandran, Suraj Peri, et al.
Molecular Cancer Therapeutics|May 10, 2013
NF-κB inhibition by bortezomib permits IFN-γ-activated RIP1 kinase-dependent necrosis in renal cell carcinomaRoshan J Thapa, Peirong Chen, Mitchell Cheung, et al.
Plos One|October 4, 2019
RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistanceShuyun Rao, Suraj Peri, Jens Hoffmann, et al.
Frontiers in Oncology|August 5, 2025
Bladder cancer microbiome and its association with chemoresponseRashida Ginwala, Laura Bukavina, Mohit Sindhani, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Unique vulnerability of <i>RAC1</i>-mutant melanoma to combined inhibition of CDK9 and immune checkpointsAlexa C Cannon, Konstantin Budagyan, Cristina Uribe-Alvarez, et al.
Plos Pathogens|December 19, 2014
Cellular oxidative stress response controls the antiviral and apoptotic programs in dengue virus-infected dendritic cellsDavid Olagnier, Suraj Peri, Courtney Steel, et al.
Oncogene|January 19, 2024
Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpointsAlexa C Cannon, Konstantin Budagyan, Cristina Uribe-Alvarez, et al.
Molecular & Cellular Proteomics : MCP|September 30, 2020
Kinome Profiling of Primary Endometrial Tumors Using Multiplexed Inhibitor Beads and Mass Spectrometry Identifies SRPK1 as Candidate Therapeutic TargetAlison M Kurimchak, Vikas Kumar, Carlos Herrera-Montávez, et al.
Molecular Biology and Evolution|October 9, 2018
Functional Conservation of a Developmental Switch in Mammals since the Jurassic AgeJayati Mookerjee-Basu, Xiang Hua, Lu Ge, et al.
Pageof 7